Search Results - HIV vaccine development
-
1
Development of murine immune responses to H5 DNA vaccine with IRF3 as genetic adjuvant and HIV Tat-conjugated pamam dendrimer as the delivery system
Published 2016“…This study provides valuable information for further study to determine the efficacy of the developed DNA vaccine to induce protection against challenge with virulent H5N1 virus.…”
Get full text
Get full text
-
2
Development of tat - conjugated dendrimer for transdermal DNA vaccine delivery
Published 2016“…PURPOSE: In order to enhance cellular uptake and to facilitate transdermal delivery of DNA vaccine, polyamidoamine (PAMAM) dendrimers conjugated with HIV transactivator of transcription (TAT) was developed. …”
Get full text
Get full text
-
3
Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines
Published 2011“…This article discusses many of the critical issues that need to be considered when developing fast, effective, and reliable plasmid DNA vaccine manufacturing processes. …”
Get full text
-
4
Press coverage of HIV/AIDS in Northern Nigeria: a study of daily trust
Published 2018“…In scoring the press in health priorities (particularly HIV/AIDS) against the backdrop of prescriptions of Development Media Theory in developing countries like Nigeria, this study attempts to investigate the major consistent newspaper in northern Nigeria, the Daily Trust, on its coverage of HIV/AIDS. …”
Get full text
Get full text
-
5
Valuation of primers for the detection of hiv-1 viruses from Kelantan by using reverse transcription polymerase chain Reaction (RT-PCR)
Published 2013“…Since the evolutionary change of the virus is at rapid rate, it imposes a challenge on HIV diagnostic development, vaccine development, antiretroviral drug sensitivity and drug resistance. …”
Get full text
Get full text
-
6
Evaluation of primers for the detection of HIV-1 viruses from Kelantan by using Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Published 2013“…Since the evolutionary change of the virus is at rapid rate, it imposes a challenge on HIV diagnostic development, vaccine development, antiretroviral drug sensitivity and drug resistance. …”
Get full text
Get full text
-
7
Sequencing directly from clinical specimens reveals genetic variations in HCMV-encoded chemokine receptor us28 that may influence antibody levels and interactions with human chemok...
Published 2021“…The data delineate a novel approach to understanding the pathogenesis of HCMV and may impact the development of an effective vaccine.…”
Get full text
Get full text
-
8
-
9
Malawi and Millennium Development Goal 4: A Countdown to 2015 country case study
Published 2016“…Results from the LiST analysis show that about 280 000 children's lives were saved between 2000 and 2013, attributable to interventions including treatment for diarrhoea, pneumonia, and malaria (23%), insecticide-treated bednets (20%), vaccines (17%), reductions in wasting (11%) and stunting (9%), facility birth care (7%), and prevention and treatment of HIV (7%). …”
Get full text
-
10
Exosomes in Human Immunodeficiency Virus Type I Pathogenesis: Threat or Opportunity?
Published 2016“…Deeper understanding on how exosomes promote or abate HIV infection can significantly contribute to the development of new and potent antiviral therapeutic strategy and vaccine designs.…”
Get full text
Get full text
-
11
Fighting the hepatitis B virus: past, present & future
Published 2016“…Therefore, the main aim of this talk is to provide a comprehensive review of their contributions in the development of vaccines, diagnostic assays, therapeutics and drug delivery systems to fight HBV.…”
Get full text
Get full text
-
12
Carbohydrate-mimetic peptides: structural aspects of mimicry and therapeutic implications
Published 2011“…Introduction: The existence of specific carbohydrates on the surface of a wide range of cells provides the opportunity for the development of highly targeted therapeutic agents. The potential applications of such agents are diverse, and include vaccines against pathogenic microorganisms, cancer and HIV, and anti-rejection agents for organ transplantation. …”
Get full text
-
13
Review of epidemiology, prevention and management of blood-borne viruses experienced by Aboriginal and Torres Strait Islander peoples
Published 2024“…This review provides insights to guide public health responses and policy development aimed at reducing the impact of BBVs among Aboriginal and Torres Strait Islander peoples.…”
Get full text
Get full text
-
14
Biopharmaceuticals protection, cure and the real winner
Published 2011“…Despite numbers of failures in the past, many biopharmaceutical companies are not discouraged to develop difficult vaccines against major problems or complex diseases including malaria, dengue, hepatitis C and HIV. …”
Get full text
Get full text
Get full text
-
15
Biopsychosocial risk factors and knowledge of cervical cancer among young women: A case study from Kenya to inform HPV prevention in Sub-Saharan Africa
Published 2020“…Background: Cervical cancer is the second most common female reproductive cancer after breast cancer with 84% of the cases in developing countries. A high uptake of human papilloma virus (HPV) vaccination and screening, and early diagnosis leads to a reduction of incidence and mortality rates. …”
Get full text
-
16
Design, synthesis, and evaluation of inhibitors of InhA to prevent cell wall biosynthesis in Mycobacterium bovis
Published 2020“…It is classified as both a major health threat and cattle farming threat as well as a leading cause of death worldwide ranked alongside HIV and in 2016, 1.6 million people died as a result of the disease. …”
Get full text
-
17
An assessment of the sharps management practices in health care establishments in Pahang, Malaysia: organisational factor
Published 2018“…The increasing number of healthcare services facilities to accommodate the needs of population growth especially in developing countries including Malaysia has definitely increase the prevalence of needle sticks injury (NSI) among the health care workers (HCWs). …”
Get full text
Get full text